20,820 Shares in Option Care Health, Inc. (NASDAQ:OPCH) Acquired by Point72 DIFC Ltd

Point72 DIFC Ltd bought a new stake in Option Care Health, Inc. (NASDAQ:OPCH) during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 20,820 shares of the company’s stock, valued at approximately $652,000.

A number of other large investors also recently added to or reduced their stakes in the company. Blue Trust Inc. raised its holdings in shares of Option Care Health by 14.8% in the 2nd quarter. Blue Trust Inc. now owns 2,931 shares of the company’s stock valued at $81,000 after buying an additional 377 shares during the period. GAMMA Investing LLC increased its stake in Option Care Health by 110.6% during the third quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock worth $28,000 after purchasing an additional 471 shares during the period. Lindenwold Advisors INC lifted its position in shares of Option Care Health by 5.4% during the third quarter. Lindenwold Advisors INC now owns 9,548 shares of the company’s stock worth $299,000 after purchasing an additional 489 shares in the last quarter. Trust Point Inc. boosted its stake in shares of Option Care Health by 2.6% in the third quarter. Trust Point Inc. now owns 24,124 shares of the company’s stock valued at $755,000 after purchasing an additional 622 shares during the period. Finally, Nisa Investment Advisors LLC grew its holdings in shares of Option Care Health by 5.4% in the second quarter. Nisa Investment Advisors LLC now owns 13,581 shares of the company’s stock valued at $376,000 after purchasing an additional 690 shares in the last quarter. 98.05% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on OPCH. Bank of America lowered shares of Option Care Health from a “buy” rating to a “neutral” rating and reduced their target price for the stock from $43.00 to $29.00 in a report on Wednesday, October 30th. Barrington Research decreased their target price on Option Care Health from $40.00 to $32.00 and set an “outperform” rating for the company in a report on Thursday, October 31st. Jefferies Financial Group downgraded Option Care Health from a “buy” rating to a “hold” rating and cut their price target for the stock from $38.00 to $26.00 in a report on Thursday, October 31st. JMP Securities lifted their price objective on Option Care Health from $36.00 to $37.00 and gave the company a “market outperform” rating in a research note on Monday, September 30th. Finally, UBS Group began coverage on shares of Option Care Health in a research note on Thursday. They set a “neutral” rating and a $26.00 target price on the stock. Four investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to MarketBeat, Option Care Health has a consensus rating of “Hold” and a consensus price target of $30.14.

Option Care Health Trading Down 4.1 %

OPCH opened at $22.72 on Friday. The business’s 50-day simple moving average is $26.21 and its 200-day simple moving average is $28.71. The company has a market cap of $3.87 billion, a P/E ratio of 19.09, a PEG ratio of 2.44 and a beta of 1.33. Option Care Health, Inc. has a one year low of $21.39 and a one year high of $34.63. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73.

Insider Buying and Selling at Option Care Health

In other news, Director Harry M. Jansen Kraemer, Jr. acquired 43,000 shares of the company’s stock in a transaction on Friday, November 8th. The shares were bought at an average price of $22.54 per share, with a total value of $969,220.00. Following the completion of the acquisition, the director now owns 326,334 shares in the company, valued at $7,355,568.36. This trade represents a 15.18 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. 0.64% of the stock is currently owned by insiders.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.